Cloud-Clone Corp. – USA/China

CLOUD-CLONE CORP. (CCC, USA), a research and experimental development in molecular biology and immunology oriented company headquartered in Houston, is the owner of the trade mark “Cloud-Clone”. Its main business includes production of assay reagent, manufacture of analysis equipment and service for animal experiment.

Cloud-Clone Corp. (CCC, Wuhan) is located in Export Processing Zone. Its quality management system is certified with ISO 9001:2008 and ISO 13485:2003. The featured products are reagents for life science research. 75% of the customers come from USA and Europe. Based on profound accumulation of technology and huge resource of primers, cDNAs, plasmids, hybridoma cells, as well as semi-products of detection reagent, CCC can provide 11,000 proteins, 19,000 antibodies and 7,000 immunoassay kits with short lead time. The Protein Center has four production platforms, including polypeptide synthesis platform, small-molecule modification platform, natural protein extraction platform, recombinant protein expression and purification platform using prokaryotic (E.coli) and eukaryotic (yeast, baculovirus or mammalian cells) expression systems. The Antibody Center has established a high-throughput technology platform for monoclonal, polyclonal and cloudclonal antibody production. The Preparation Center focuses on assay kit development and production. At present, its main products include ELISA kits and CLIA kits. The Detection Center is responsible for quality control of all the products, including proteins, antibodies and assay kits. All Cloud-Clone products are inspected by a three-level quality control system, including raw-material QC, semi-finished product QC, and end-product QC.

February 2019
M T W T F S S
« Apr    
 123
45678910
11121314151617
18192021222324
25262728  

©OrientBioscience